<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T02:36:18Z</responseDate>
  <request identifier="oai:figshare.com:article/34040472" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34040472</identifier>
        <datestamp>2026-10-01T06:12:43Z</datestamp>
        <setSpec>category_46</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Additional file 1 of Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression</dc:title>
          <dc:creator>Alexandros Lalos (25153584)</dc:creator>
          <dc:creator>Marina Lovrinovic (25153587)</dc:creator>
          <dc:creator>Katharina Andersen (25153590)</dc:creator>
          <dc:creator>Alberto Posabella (7400150)</dc:creator>
          <dc:creator>Uwe Güth (311981)</dc:creator>
          <dc:creator>Sylvia Stadlmann (25153593)</dc:creator>
          <dc:creator>Tarik Delko (4041038)</dc:creator>
          <dc:creator>Raoul A. Droeser (8508228)</dc:creator>
          <dc:creator>Gad Singer (68052)</dc:creator>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>High-grade serous ovarian cancer</dc:subject>
          <dc:subject>PD-1</dc:subject>
          <dc:subject>PD-L1</dc:subject>
          <dc:subject>Tissue microarray</dc:subject>
          <dc:subject>Immunohistochemistry</dc:subject>
          <dc:subject>Prognosis</dc:subject>
          <dc:subject>Biomarker</dc:subject>
          <dc:subject>Recurrence</dc:subject>
          <dc:subject>Survival</dc:subject>
          <dc:subject>Chemosensitivity</dc:subject>
          <dc:description>Supplementary Material 1.</dc:description>
          <dc:date>2026-07-08T05:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34040472.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Additional_file_1_of_Recurrence-free_survival_is_prolonged_in_high-grade_serous_ovarian_cancer_with_high_PD-L1_expression/34040472</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
